Cargando…
An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals
Glioblastomas (GBM) are largely incurable as they diffusely infiltrate adjacent brain tissues and are difficult to diagnose at early stages. Biomarkers derived from serum, which can be obtained by minimally invasive procedures, may help in early diagnosis, prognosis and treatment monitoring. To deve...
Autores principales: | Nijaguna, Mamatha B., Patil, Vikas, Hegde, Alangar S., Chandramouli, Bangalore A., Arivazhagan, Arimappamagan, Santosh, Vani, Somasundaram, Kumaravel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577083/ https://www.ncbi.nlm.nih.gov/pubmed/26390214 http://dx.doi.org/10.1371/journal.pone.0137524 |
Ejemplares similares
-
miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
por: Rao, Soumya Alige Mahabala, et al.
Publicado: (2013) -
PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA
por: Nawaz, Zahid, et al.
Publicado: (2016) -
Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription
por: Nawaz, Zahid, et al.
Publicado: (2016) -
IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65
por: Bhargava, Shruti, et al.
Publicado: (2017) -
Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
por: Pal, Jagriti, et al.
Publicado: (2016)